The Barbara Ann Karmanos Cancer Institute
In research, The Barbara Ann Karmanos Cancer Institute stands highest in Medicine (#2,842 of 10,443 worldwide), Health Sciences (#3,970 of 11,982 worldwide) and Life Sciences (#3,253 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Oncology and Pulmonary and Respiratory Medicine — Hematology is 19.4× its share of world research.
- World rank, 2022–2025
- #5,619 of 28,054 · #3,519 all time
- Rank in United States
- #764 of 4,192
- Research works
- 3.3k ▼ 9% vs 2013–17
- Citations
- 132k 40.4 per fractional work
- Top-10% rate
- 18.6% record average 16.5%
- Open access
- 40% world 28%
What is The Barbara Ann Karmanos Cancer Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,842 of 10,443 | 18.2% | 210 | #1328 | |
| Health SciencesDomain | #3,970 of 11,982 | 18.4% | 218 | #1642 | |
| Life SciencesDomain | #3,253 of 7,800 | 19.0% | 97 | #1865 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,295 of 3,579 | 18.8% | 81 | #1624 |
Each strip is that field’s whole ranked pool, with the notch where The Barbara Ann Karmanos Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,328 #2,842
- Health Sciences#1,642 #3,970
- Life Sciences#1,865 #3,253
- Biochemistry, Genetics and Molecular Biology#1,624 #2,295
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does The Barbara Ann Karmanos Cancer Institute specialise in?
Where its research is concentrated relative to its size: Hematology takes 19.4× the share of its output that it takes of world research.
- HematologySubfield · 21.1 works19×
- OncologySubfield · 59.1 works15×
- Pulmonary and Respiratory MedicineSubfield · 30.4 works5.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.2×
- Immunology and Microbiology 3.1×
- Medicine 3.0×
- Chemistry 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Health Professions 0.7×
- Physics and Astronomy 0.7×
- Mathematics 0.6×
- Economics, Econometrics and Finance 0.6×
- Neuroscience 0.4×
- Nursing 0.3×
- Materials Science 0.3×
- Veterinary 0.3×
- Decision Sciences 0.3×
- Dentistry 0.2×
- Psychology 0.2×
- Computer Science 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Arts and Humanities 0.0×
- Earth and Planetary Sciences 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at The Barbara Ann Karmanos Cancer Institute?
Ranked on the composite score, Shirish M. Gadgeel, Anthony F. Shields and Jeffrey A. Zonder lead among researchers whose main affiliation is The Barbara Ann Karmanos Cancer Institute.
- 1 Shirish M. Gadgeel United States · #5,375 worldwide 1.2k citations · 112 works
- 2 Anthony F. Shields United States · #92,670 worldwide 305 citations · 76 works
- 3 Jeffrey A. Zonder United States · #131,321 worldwide 166 citations · 37 works
- 4 Peter J. Littrup United States · #156,396 worldwide 142 citations · 26 works
- 5 Radhakrishnan Ramchandren United States · #170,386 worldwide 171 citations · 22 works
- 6 Ammar Sukari United States · #203,562 worldwide 130 citations · 40 works
- 7 Antoinette J. Wozniak United States · #208,363 worldwide 173 citations · 24 works
- 8 F. H. Sarkar United States · #279,418 worldwide 102 citations · 24 works
- 9 Michael S. Simon United States · #452,733 worldwide 82 citations · 53 works
- 10 Philip Agop Philip United States · #456,131 worldwide 80 citations · 19 works
Which keywords describe research at The Barbara Ann Karmanos Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Cancer, Prognostic Factors, Tumor Microenvironment, Clinical Trials, Targeted Therapy and Cancer Therapy.
- Treatment Guidelines
- Homologous Recombination
- Prostate Cancer
- PD-1 and PD-L1
- Tumor Regression
- Magnetic Resonance Imaging
- Acute Myeloid Leukemia
- Gene Expression
- Clinical Practice Guidelines
- Neoadjuvant Therapy
- Cancer Incidence
- Lymphoma
- Hematopoietic Stem Cells
- Breast Cancer
- Metastasis
- Biomarkers
- Cancer Therapy
- Clinical Trials
- Prognostic Factors
- Chemotherapy
- Immunotherapy
- Cancer
- Tumor Microenvironment
- Targeted Therapy
- Inflammation
- Radiotherapy
- Genetic Mutations
- Genomic Profiling
- Cell Death
- Survival Analysis
- Precision Medicine
- Cancer Immunotherapy
- PET Imaging
- AML
- Genomic Instability
- Immunity
- Immune Checkpoint Blockade
- Apoptosis
- Minimal Residual Disease
- Population-Based Study
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy32▲ 13×16 topics
- Chemotherapy31▲ 12×23 topics
- Cancer28▲ 5.8×42 topics
- Prognostic Factors23▲ 15×13 topics
- Tumor Microenvironment23▲ 14×8 topics
- Clinical Trials21▲ 8.9×11 topics
- Targeted Therapy20▲ 25×5 topics
- Cancer Therapy18▲ 8.9×16 topics
- Inflammation18▲ 2.4×56 topics
- Biomarkers16▲ 6.5×13 topics
- Radiotherapy14▲ 10×11 topics
- Metastasis13▲ 11×12 topics
- Genetic Mutations12▲ 7.6×15 topics
- Breast Cancer12▲ 14×11 topics
- Genomic Profiling12▲ 31×2 topics
- Hematopoietic Stem Cells11▲ 35×3 topics
- Cell Death10▲ 12×6 topics
- Lymphoma10▲ 17×4 topics
- Survival Analysis10▲ 9.8×6 topics
- Cancer Incidence10▲ 19×4 topics
- Precision Medicine10▲ 5.6×8 topics
- Neoadjuvant Therapy9▲ 11×5 topics
- Cancer Immunotherapy9▲ 17×3 topics
- Clinical Practice Guidelines9▲ 4.7×11 topics
- PET Imaging9▲ 15×4 topics
- Gene Expression9▲ 4.1×14 topics
- AML9▲ 50×1 topic
- Acute Myeloid Leukemia9▲ 50×1 topic
- Genomic Instability9▲ 22×3 topics
- Magnetic Resonance Imaging8▲ 9.2×6 topics
- Immunity8▲ 5.8×7 topics
- Tumor Regression8▲ 21×2 topics
- Immune Checkpoint Blockade8▲ 20×1 topic
- PD-1 and PD-L18▲ 20×1 topic
- Apoptosis8▲ 7.1×14 topics
- Prostate Cancer7▲ 16×4 topics
- Minimal Residual Disease7▲ 29×2 topics
- Homologous Recombination7▲ 41×2 topics
- Population-Based Study7▲ 28×2 topics
- Treatment Guidelines6▲ 8.3×4 topics
Which research topics does The Barbara Ann Karmanos Cancer Institute publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 9 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 4 Cancer Genomics and Diagnostics Cancer Research 6 works
- 5 CAR-T cell therapy research Oncology 6 works
- 6 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 5 works
- 7 Lung Cancer Research Studies Oncology 5 works
- 8 Global Cancer Incidence and Screening Oncology 5 works
- 9 PARP inhibition in cancer therapy Oncology 5 works
- 10 Multiple Myeloma Research and Treatments Hematology 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has The Barbara Ann Karmanos Cancer Institute's research output changed?
Output in 2018–2022 was 9% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Detroit
- Wayne State University
- Henry Ford Hospital
- General Motors (United States)
- Henry Ford Health System
- University of Detroit Mercy
- Children's Hospital of Michigan
- Detroit Medical Center
- Detroit R&D (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.